Profesor Titular, Departamento de Ginecología y Obstetricia, Hospital de San José de Bogotá, Fundación Universitaria de Ciencias de la Salud. Bogotá (Colombia).
Residente de cuarto año de Ginecología y Obstetricia, Hospital de San José de Bogotá, Fundación Universitaria de Ciencias de la Salud. Bogotá (Colombia).
Rev Colomb Obstet Ginecol. 2024 Sep 2;75(2):4187. doi: 10.18597/rcog.4187.
To determine the general state of scientific evidence published in the last 20 years on gastric signet ring cell (SRC) adenocarcinoma metastatic to the breast, and present a case.
The case of a patient who attended a high-complexity reference institution in Bogotá for a breast metastasis from a gastric SRC adenocarcinoma is reported. A Systematic Review of the literature was carried out, including cohort studies, reports and case series of patients with gastric SRC adenocarcinoma metastatic to the breast, which will present information on the epidemiology, clinical, radiological and histopathological characteristics, and the treatment and prognostic of this disease.
There were identified 363 references, twenty-six of which met the eligibility criteria. Gastric SRC adenocarcinoma metastatic to the breast predominated in the Asian continent (75.9%). The mean age at presentation was 42.5 years. In 62% (n=18) of cases this condition manifested clinically as a breast mass. From a radiological point of view, the majority of breast lesions presented as one or several nodules with suspicious characteristics (55.2%; n=16). In the biopsy of breast lesions, positivity for cytokeratin 7 and cytokeratin 20 occurred in 41.4% (n=12) and 37.9% (n=11) of cases, respectively. Only nine patients (31%) underwent any type of breast surgery. There is a lack of information on the treatment and prognosis of gastric SRC adenocarcinoma metastatic to the breast.
The frequency of cases of gastric SRC adenocarcinoma metastatic to the breast published in the last 20 years is low. The general practitioner and the gynecologist could be the first medical professionals to face this rare condition, so knowing it and suspecting it is essential, especially if we take into account that the median overall survival of these patients is low.
确定过去 20 年发表的关于胃印戒细胞(SRC)腺癌转移至乳腺的一般科学证据,并报告 1 例病例。
报告了 1 例在波哥大一家高复杂度参考机构就诊的患者,该患者患有胃 SRC 腺癌转移至乳腺的乳腺癌。进行了系统的文献回顾,包括队列研究、胃 SRC 腺癌转移至乳腺的患者报告和病例系列,这些将提供有关该疾病的流行病学、临床、放射学和组织病理学特征以及治疗和预后的信息。
共确定了 363 篇参考文献,其中 26 篇符合入选标准。胃 SRC 腺癌转移至乳腺主要发生在亚洲大陆(75.9%)。就诊时的平均年龄为 42.5 岁。在 62%(n=18)的病例中,这种情况临床上表现为乳腺肿块。从放射学角度来看,大多数乳腺病变表现为一个或多个具有可疑特征的结节(55.2%;n=16)。在乳腺病变的活检中,细胞角蛋白 7 和细胞角蛋白 20 的阳性率分别为 41.4%(n=12)和 37.9%(n=11)。仅有 9 例患者(31%)接受了任何类型的乳腺手术。关于胃 SRC 腺癌转移至乳腺的治疗和预后信息缺乏。
过去 20 年发表的胃 SRC 腺癌转移至乳腺的病例频率较低。普通医生和妇科医生可能是最先面对这种罕见情况的医疗专业人员,因此了解并怀疑这种情况至关重要,特别是考虑到这些患者的中位总生存期较低。